Sector: Pharmaceuticals & Biotechnology

Large Cap

Emcure Pharma Share Price

Emcure Pharmaceuticals Ltd.

₹1,431.80

-6.10(-0.42%)

Invest in EMCURE with up to 2.86x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : EMCURE

Open Free Demat Account

Emcure Pharma Performance

Price Movement

₹1431.80

₹1386.30

₹1438.30

↘ Today's Low↗ Today's High

1 Year Performance

₹1431.80

₹889.00

₹1585.60

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,438.30

Low₹1,386.30

Open at₹1,415.00

Prev Close₹1,437.90

Volumes2.29 L

Avg Price₹1,412.32

Lower Circuit₹1,294.20

Upper Circuit₹1,581.60

Historical Performance

3M High₹1,585.60

3M Low₹1,312.30

1 Yr High₹1,585.60

1 Yr Low₹889.00

3 Yr High₹1,585.60

3 Yr Low₹889.00

5 Yr High₹1,585.60

5 Yr Low₹889.00

Emcure Pharma Fundamentals

Market Cap

High in industry

27,215 Cr.

PE Ratio (TTM)

Above industry Median

31.30

Dividend Yield

Low in industry

0.20

Net Profit TTM

43.2% incr over last year

869.92

Net Profit Growth

43.2% incr over last year

869.92

PEG Ratio

Above industry Median

0.70

ROE

9% decr over last year

15.32

Operating Revenue TTM

8,850.08

Operating Revenue Growth

17.2% incr over last year

Book Value

High in industry

5.70

MFI

MFI is mid-range

54.05

RSI

RSI is mid-range

42.98

EPS (TTM)

36.43

Debt to Equity

0.16

Face Value

Operating Profit Margin Qtr.

18.51

Operating Profit Qtr.

492.74

Net Profit Qtr.

230.54

Operating Revenue Qtr.

2,363.48

PB Ratio

5.70

Emcure Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	1,418.31	1,260.60	1,096.57	1,278.19	1,028.81
Operating Expense	1,117.80	1,036.01	868.57	1,033.55	904.40
Operating Profit	300.50	224.59	228	244.64	124.42
Depreciation	62.14	61.74	59.82	56.91	56.65
Interest	33.15	27.71	20.54	24.07	19.93
Tax	55.51	40.27	42.88	46.50	17.05
Net Profit	258.85	117.62	122.79	139.56	50.20

Emcure Pharma Technicals

Emcure Pharmaceuticals Ltd. EMA & SMA

₹1431.80

-6.10 (-0.42%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1453

Day EMA10 ₹1467.5

Day EMA12 ₹1471.2

Day EMA20 ₹1478.8

Day EMA26 ₹1479.5

Day EMA50 ₹1467.1

Day EMA100 ₹1433.3

Day EMA200 ₹1392.7

Emcure Pharma Support and Resistance

Resistance

First Resistance₹1448.73

Second Resistance₹1459.57

Third Resistance₹1474.13

Support

First Support₹1423.33

Second Support₹1408.77

Third Support₹1397.93

Technical Indicators

Day RSI42.98

Day MFI54.05

Day ADX19.62

Day Commodity Channel Index-129.10

William-87.43

Day MACD-8.34

Day MACD Signal Line0.76

Day ATR49.55

Day ROC125-2.18

Day ROC21-7.73

Emcure Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	78.1	77.9	77.9	77.9	77.9	77.9
FII	2.9	3	3.1	2.9	3.3	3.6
DII	4	3.9	3.4	2.8	4.3	6.1
Public	15	15.2	15.6	16.4	14.5	12.4

Emcure Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	35.56 K	71.37 K	49.82%
Week	40.65 K	75.75 K	53.66%
1 Month	63.83 K	1.37 L	46.60%
6 Month	1.37 L	2.29 L	59.78%

Emcure Pharma SWOT Analysis

Strengths14

Weakness9

Opportunity7

Threats1

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

PEG lower than Industry PEG

Good quarterly growth in the recent results

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Emcure Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
14 Aug, 2025	3	FINAL	14 Aug, 2025	Equity Share

Emcure Pharma Stock Comparison

Financials	Anthem Biosciences Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.	Gland Pharma Ltd.	Laurus Labs Ltd.
Price (₹)	₹696.90	₹2,045	₹162	₹1,803	₹1,014.60
% Change	2.20%	1.02%	0.92%	-1.03%	-0.43%
Revenue TTM (₹ Cr)	₹1,996.59	₹13,914.08	₹8,871.37	₹6,112.77	₹6,721.63
Net Profit TTM (₹ Cr)	₹484.66	₹1,779.35	₹-163.61	₹847.18	₹843.32
PE TTM	80.70	47.50	-131.70	35.10	65.10
1 Year Return	22.17	-12.08	-22.44	18.09	95.04
ROCE	26.88	13.27	6.40	11.43	11.82

Similar Stocks

ALKEM

Alkem Laboratories Ltd.

₹ 5487.00

+1.76%

BIOCON

Biocon Ltd.

₹ 388.00

+1.05%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6258.50

-0.52%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 2975.00

+1.21%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 905.30

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2033.00

-0.50%

WOCKPHARMA

Wockhardt Ltd.

₹ 1370.00

-0.84%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1148.70

-0.87%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1732.00

+0.44%

IPCALAB

Ipca Laboratories Ltd.

₹ 1469.70

+1.37%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2051.00

+2.53%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8807.00

-0.93%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2635.30

+1.48%

PFIZER

Pfizer Ltd.

₹ 5066.60

+2.74%

ABBOTINDIA

Abbott India Ltd.

₹ 26425.00

+0.49%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4318.50

+1.81%

LUPIN

Lupin Ltd.

₹ 2241.00

+0.97%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1305.10

+1.93%

CIPLA

Cipla Ltd.

₹ 1327.00

-1.05%

FAQ's on EMCURE

What is the current share price of Emcure Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Emcure Pharmaceuticals Ltd. is ₹ 1431.8 on the NSE and ₹ 1436.85 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Emcure Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Emcure Pharmaceuticals Ltd. is approximately ₹ 27215 Cr.

What are the PE and PB ratios for Emcure Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Emcure Pharmaceuticals Ltd. is 31.3, and the Price-to-Book (PB) ratio is 5.7.

What is the 52-Week High and Low for Emcure Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Emcure Pharmaceuticals Ltd. shares was ₹ 1585.6, and the lowest price was ₹ 889.

What is the current dividend yield for Emcure Pharmaceuticals Ltd.?

As of 6 June 2025, the dividend yield for Emcure Pharmaceuticals Ltd. is 0.2%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Emcure Pharmaceuticals Ltd.?

Significant shareholdings in Emcure Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Emcure Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Emcure Pharmaceuticals Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Emcure Pharmaceuticals Ltd.?

Emcure Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 3 per share for the financial period ending 2025. The record date was set as 2025-08-14, and the payment was/is scheduled around 2025-08-14. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy